rs727503074

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_032119.4(ADGRV1):ā€‹c.5311C>Gā€‹(p.Gln1771Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,611,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000026 ( 0 hom., cov: 32)
Exomes š‘“: 0.000021 ( 0 hom. )

Consequence

ADGRV1
NM_032119.4 missense, splice_region

Scores

18
Splicing: ADA: 0.003896
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.35
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15879557).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADGRV1NM_032119.4 linkuse as main transcriptc.5311C>G p.Gln1771Glu missense_variant, splice_region_variant 24/90 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkuse as main transcriptc.5311C>G p.Gln1771Glu missense_variant, splice_region_variant 24/901 NM_032119.4 ENSP00000384582.2 Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152112
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000212
AC:
31
AN:
1459590
Hom.:
0
Cov.:
30
AF XY:
0.0000152
AC XY:
11
AN XY:
725930
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000270
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152112
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74308
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 29, 2013Variant classified as Uncertain Significance - Favor Benign. The Gln1771Glu vari ant in GPR98 has not been reported in individuals with hearing loss or in large population studies. The glutamine (Gln) residue at position 1771 is not well con served in distant species and computational analyses (biochemical amino acid pro perties, AlignGVGD, PolyPhen2, and SIFT) suggest that the Gln1771Glu variant may not impact the protein. However, this information is not predictive enough to r ule out pathogenicity. In summary, the clinical significance of this variant ca nnot be determined with certainty; however based upon the conservation and compu tational data, we would lean towards a more likely benign role. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
18
DANN
Benign
0.87
DEOGEN2
Benign
0.068
T;T;.
Eigen
Benign
-0.097
Eigen_PC
Benign
0.069
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.76
.;T;T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.16
T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.65
.;N;.
REVEL
Benign
0.047
Sift
Benign
0.55
.;T;.
Sift4G
Benign
0.49
.;T;.
Polyphen
0.25
B;B;.
Vest4
0.37
MutPred
0.30
Gain of disorder (P = 0.0628);Gain of disorder (P = 0.0628);.;
MVP
0.41
MPC
0.28
ClinPred
0.67
D
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Varity_R
0.14
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0039
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727503074; hg19: chr5-89971260; API